[spacer image]
BD
[spacer image]
BD Stock Price
[spacer image]
Annual Reports / Proxy
[spacer image]
Contact Us/
Request Information
[spacer image]
Corporate Governance
[spacer image]
Events
[spacer image]
FAQs
[spacer image]
Financial Information
[spacer image]
Investor Alerts
[spacer image]
Press Releases
[spacer image]
Quarterly Earnings Releases/
Presentations/
Supplemental Information
[spacer image]
SEC Filings / Section 16 Reports
[spacer image]
Stock Information
[spacer image]
Worldwide Business Segments
[spacer image]
Investors Home
[spacer image]
[spacer image]



Press Releases
BookmarkPrint

[spacer image]


Investor E-mail Alert Service: You can automatically receive Press Release alerts via e-mail by subscribing now.

Keyword Search
 
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
DateTitle 
11/20/09BD Completes Acquisition of HandyLab, Inc.Printer Friendly Version
11/04/09BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
11/04/09Q4 2009 Supplemental Information (PDF)Printer Friendly Version
11/04/09BD Announces Results for Fourth Fiscal Quarter and Full YearPrinter Friendly Version
10/23/09BD Announces Agreement to Acquire HandyLab, Inc.Printer Friendly Version
10/07/09BD Ranked in the Top 100 Greenest Big Companies by Newsweek; Named Again to Dow Jones Sustainability World and North America IndexesPrinter Friendly Version
10/06/09BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference CallPrinter Friendly Version
09/03/09BD Announces Flu Product Order from U.S. GovernmentPrinter Friendly Version
09/01/09BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
08/11/09BD and PEPFAR Collaboration Will Improve Blood-Drawing Practices in Hospitals and Clinics in Sub-Saharan AfricaPrinter Friendly Version
08/10/09Q3 2009 Supplemental Information (PDF)Printer Friendly Version
08/06/09BD Adds Surveillance Capability to Infectious Disease PortfolioPrinter Friendly Version
07/30/09Q3 2009 Earnings Presentation (PDF) Printer Friendly Version
07/30/09BD Announces Results for Third Fiscal QuarterPrinter Friendly Version
07/28/09BD Board Declares DividendPrinter Friendly Version
07/19/09BD/PEPFAR Lab-Strengthening Initiative Marks Progress in Fight Against HIV/AIDS and TB in Sub-Saharan AfricaPrinter Friendly Version
06/29/09BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference CallPrinter Friendly Version
06/17/09BD and FIND Achieve Milestone in Global Battle Against MDR-TBPrinter Friendly Version
06/01/09BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
05/20/09BD Board Declares DividendPrinter Friendly Version
05/18/09BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular AssaysPrinter Friendly Version
05/08/09BD Extends Decade-Long Support for UNICEF's Campaign to Eliminate Maternal and Neonatal TetanusPrinter Friendly Version
05/04/09BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and ManagementPrinter Friendly Version
05/01/09BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
04/28/09Q2 2009 Earnings Presentation (PDF)Printer Friendly Version
04/28/09BD Announces Results for Second Fiscal QuarterPrinter Friendly Version
04/01/09BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference CallPrinter Friendly Version
03/11/09BD Named to 100 Best Corporate Citizens List by CRO MagazinePrinter Friendly Version
03/05/09BD to Present at the Cowen and Company 29th Annual Healthcare ConferencePrinter Friendly Version
02/23/09BD Ranks 23rd on EPA's Fortune 500 List of Green Power PurchasersPrinter Friendly Version
02/03/09BD Announces Results of Shareholder Votes at Annual MeetingPrinter Friendly Version
02/03/09BD Board Declares DividendPrinter Friendly Version
01/28/09BD Announces Results for First Fiscal QuarterPrinter Friendly Version
01/14/09BD Announces Webcast of Annual Meeting of ShareholdersPrinter Friendly Version
01/14/09BD Announces Live Webcast of First Fiscal Quarter Earnings Conference CallPrinter Friendly Version
01/12/09BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile InfectionsPrinter Friendly Version
12/24/08BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
12/04/08BD Receives FDA Approval for the BD FocalPoint(TM) GS Imaging System to Enhance the Detection of Cervical CancerPrinter Friendly Version
11/25/08BD Board Declares Dividend Increase and Authorizes Additional Share RepurchasesPrinter Friendly Version
11/05/08BD Announces Executive Appointments of President and Chief Financial OfficerPrinter Friendly Version
11/05/08BD Announces Results for Fourth Fiscal Quarter and Full YearPrinter Friendly Version
11/03/08BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
10/02/08BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference CallPrinter Friendly Version
09/25/08Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo HospitalPrinter Friendly Version
08/27/08BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
07/24/08BD Announces Results for Third Fiscal QuarterPrinter Friendly Version
07/22/08BD Board Declares DividendPrinter Friendly Version
07/07/08BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile InfectionsPrinter Friendly Version
06/24/08BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference CallPrinter Friendly Version
06/03/08BD to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare ConferencePrinter Friendly Version
05/20/08BD Board Declares DividendPrinter Friendly Version
05/13/08BD Announces Acquisition of CytopeiaPrinter Friendly Version
05/07/08BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
04/23/08BD to Present at the 2008 Morgan Stanley Global Healthcare Unplugged ConferencePrinter Friendly Version
04/23/08BD Announces Results for Second Fiscal QuarterPrinter Friendly Version
03/27/08BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in GhanaPrinter Friendly Version
03/26/08BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference CallPrinter Friendly Version
03/26/08BD to Present at the Leerink Swann Molecular Diagnostics Roundtable ConferencePrinter Friendly Version
03/18/08BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of DirectorsPrinter Friendly Version
03/17/08BD GeneOhm(TM) MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection RatesPrinter Friendly Version
03/07/08BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
01/29/08BD Announces Results of Shareholder Votes at Annual MeetingPrinter Friendly Version
01/29/08BD Board Declares DividendPrinter Friendly Version
01/28/08BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device ConferencePrinter Friendly Version
01/24/08BD Announces Results For First Fiscal QuarterPrinter Friendly Version
01/16/08BD Announces Webcast of Annual Meeting of ShareholdersPrinter Friendly Version
01/04/08BD Announces Live Webcast of First Fiscal Quarter Earnings Conference CallPrinter Friendly Version
01/02/08BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood CulturesPrinter Friendly Version
12/27/07BD to Present at the 26th Annual JPMorgan Healthcare ConferencePrinter Friendly Version
11/20/07BD Board Declares DividendPrinter Friendly Version
11/07/07BD to Present at Investor Healthcare ConferencesPrinter Friendly Version
11/05/07BD and FIND Help Address Emergence of XDR-TB With New Pricing Agreement for Liquid Culture SystemPrinter Friendly Version
11/02/07BD Board of Directors Elects Cathy E. MinehanPrinter Friendly Version
11/01/07BD Announces Results for Fourth Fiscal Quarter and Full YearPrinter Friendly Version
10/31/07BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TBPrinter Friendly Version
10/01/07BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference CallPrinter Friendly Version
09/11/07BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to SurgeryPrinter Friendly Version
08/30/07BD to Present at the Bear Stearns 20th Annual Healthcare ConferencePrinter Friendly Version
08/24/07BD to Present at the Thomas Weisel Partners Healthcare Conference 2007Printer Friendly Version
08/07/07BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology OfficerPrinter Friendly Version
07/26/07BD Announces Results for Third Fiscal QuarterPrinter Friendly Version
07/24/07BD Board Declares Dividend and Authorizes Additional Share RepurchasesPrinter Friendly Version
07/24/07BD Board of Directors Elects Marshall O. LarsenPrinter Friendly Version
06/29/07BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference CallPrinter Friendly Version
06/04/07BD to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare ConferencePrinter Friendly Version
05/22/07BD Board Declares DividendPrinter Friendly Version
05/18/07BD to Present at the Bank of America 2007 Healthcare ConferencePrinter Friendly Version
05/17/07BD to Present at the Sanford C. Bernstein & Co., LLC Twenty-Third Annual Strategic Decisions ConferencePrinter Friendly Version
04/26/07Variant Strain of Chlamydia May Go UndetectedPrinter Friendly Version
04/25/07BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood CulturesPrinter Friendly Version
04/25/07BD Discloses Notice of Arbitration and Dispute Resolution ProceedingsPrinter Friendly Version
04/25/07BD Announces Results for Second Fiscal QuarterPrinter Friendly Version
04/18/07BD to Present at the 2007 Morgan Stanley Global Healthcare Unplugged ConferencePrinter Friendly Version
03/26/07BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference CallPrinter Friendly Version
03/26/07BD and Direct Relief International Launch Volunteer Service Program to Improve Healthcare in GhanaPrinter Friendly Version
03/22/07BD and FIND Announce Expanded Collaboration to Improve Tuberculosis Diagnostics WorldwidePrinter Friendly Version
03/09/07BD Honored as One of 'America's Most Admired Companies' in FORTUNE Magazine's Annual RankingsPrinter Friendly Version
03/01/07BD to Present at the Cowen and Company 27th Annual Healthcare ConferencePrinter Friendly Version
02/26/07BD Biosciences and Roche Collaborate to Advance the Study of Cell Signal Transduction through New Phosphorylation Site Antibody Targets and ApplicationsPrinter Friendly Version
01/30/07BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device ConferencePrinter Friendly Version
01/30/07BD Announces Results of Shareholder Votes at Annual MeetingPrinter Friendly Version
01/30/07BD Board Declares DividendPrinter Friendly Version
01/25/07BD Announces Results for First Fiscal QuarterPrinter Friendly Version
01/10/07BD Announces Webcast of Annual Meeting of ShareholdersPrinter Friendly Version
12/28/06BD to Present at the 25th Annual JPMorgan Healthcare ConferencePrinter Friendly Version
12/21/06BD Announces Live Webcast of First Fiscal Quarter Earnings Conference CallPrinter Friendly Version
12/20/06BD Completes Acquisition of TriPath ImagingPrinter Friendly Version
11/30/06BD and International Council of Nurses Collaborate to Address the Health Human Resource Crisis in AfricaPrinter Friendly Version
11/21/06BD Board Declares DividendPrinter Friendly Version
11/20/06BD to Present at the Lazard Capital Markets Third Annual Life Sciences ConferencePrinter Friendly Version
11/09/06BD to Present at the 2006 Credit Suisse Healthcare ConferencePrinter Friendly Version
11/06/06BD to Present at the ArgusVision 2007: Eyes on the Future ConferencePrinter Friendly Version
11/02/06BD Announces Results for Fourth Fiscal Quarter and Full YearPrinter Friendly Version
11/01/06BD to Present at the CIBC World Markets Seventeenth Annual Healthcare ConferencePrinter Friendly Version
10/19/06BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference CallPrinter Friendly Version
09/28/06BD Announces Plan to Exit Blood Glucose Monitoring MarketPrinter Friendly Version
09/26/06BD Board of Directors Elects Dr. Claire M. Fraser-LiggettPrinter Friendly Version
09/18/06BD Biosciences Releases BD FACSCanto(TM) II Flow Cytometry System for In Vitro Diagnostics UsePrinter Friendly Version
09/08/06BD to Acquire TriPath Imaging, Inc.Printer Friendly Version
09/05/06BD to Present at the Bear Stearns 19th Annual Healthcare ConferencePrinter Friendly Version
08/31/06BD to Present at the Thomas Weisel Partners Healthcare Conference 2006Printer Friendly Version
08/14/06BD Makes Filing to Report Bid to Acquire TriPath Imaging, Inc.Printer Friendly Version
08/12/06BD Diagnostics Announces Availability in Africa of New CD4 Stabilization Blood Collection TechnologyPrinter Friendly Version
07/28/06BD Announces Results for Third Fiscal QuarterPrinter Friendly Version
07/25/06BD Board of Directors Elects Dr. Adel A.F. MahmoudPrinter Friendly Version
07/25/06BD Board Declares DividendPrinter Friendly Version
07/17/06BD Medical Announces Positive Results for New York City BD Diabetes Makeover(SM) ProgramPrinter Friendly Version
07/06/06BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper(TM) Robotic Instrumentation and Molecular Testing of Sexually Transmitted InfectionsPrinter Friendly Version
06/15/06BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference CallPrinter Friendly Version
06/12/06BD and Catholic Medical Mission Board Partner to Bolster Zambian Healthcare Clinics' HIV/AIDS EffortsPrinter Friendly Version
06/06/06BD to Present at the Goldman Sachs 27th Annual Global Healthcare ConferencePrinter Friendly Version
05/23/06BD Board Declares DividendPrinter Friendly Version
05/10/06BD to Present at the Bank of America Healthcare Conference 2006Printer Friendly Version
04/26/06BD Announces Results for Second Fiscal QuarterPrinter Friendly Version
04/24/06BD to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2006Printer Friendly Version
03/27/06BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference CallPrinter Friendly Version
03/20/06BD Medical to Support Gary Hall, Jr. Through 2008 Olympic GamesPrinter Friendly Version
03/01/06BD to Present at the SG Cowen & Co. 26th Annual Health Care ConferencePrinter Friendly Version
02/23/06BD Diagnostics Announces Multi-Year Agreement With Quest Diagnostics for BD Viper(TM) SystemPrinter Friendly Version
02/14/06BD Completes Acquisition of GeneOhm Sciences, Inc.Printer Friendly Version
02/02/06BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device ConferencePrinter Friendly Version
01/31/06BD Board Declares DividendPrinter Friendly Version
01/26/06BD Announces Results For First Fiscal QuarterPrinter Friendly Version
01/24/06BD Announces Webcast of Annual Meeting of ShareholdersPrinter Friendly Version
01/10/06BD Announces Agreement to Acquire GeneOhm Sciences, Inc.Printer Friendly Version
01/09/06BD Announces Live Webcast of First Fiscal Quarter Earnings Conference CallPrinter Friendly Version
01/09/06BD Diagnostics Announces FDA 510(k) Clearance of the BD Viper(TM) SystemPrinter Friendly Version
12/28/05BD to Present at the 24th Annual JPMorgan Healthcare ConferencePrinter Friendly Version
12/21/05BD Micro-Delivery System Licensed by Sanofi PasteurPrinter Friendly Version
12/20/05BD to Allow Poison Pill to Expire; Also Adopts New Policy Regarding Election of DirectorsPrinter Friendly Version
11/22/05BD Board Declares Dividend Increase and Authorizes Additional Share RepurchasesPrinter Friendly Version
11/07/05BD to Present at the 2005 Credit Suisse First Boston Health Care ConferencePrinter Friendly Version
11/03/05BD Announces Results for Fourth Fiscal Quarter and Full YearPrinter Friendly Version
11/02/05BD to Present at CIBC World Markets Healthcare ConferencePrinter Friendly Version
11/02/05American Red Cross and BD Announce Expanded Collaboration to Support Measles InitiativePrinter Friendly Version
10/19/05BD Diagnostics Announces FDA 510(k) Clearance for BD ProbeTec(TM) Urine Preservative Transport (UPT)Printer Friendly Version
09/27/05BD Diagnostics Announces FDA 510(k) Clearance of BD Directigen(TM) EZ Flu A+B TestPrinter Friendly Version
09/22/05BD Announces Preparation Efforts Ahead of Hurricane RitaPrinter Friendly Version
09/20/05BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference CallPrinter Friendly Version
09/01/05BD Donates $500,000 to Hurricane Katrina Disaster Relief EffortsPrinter Friendly Version
09/01/05BD to Present at Bear Stearns 18th Annual Healthcare ConferencePrinter Friendly Version
08/30/05BD to Present at Thomas Weisel Partners Healthcare Tailwinds ConferencePrinter Friendly Version
08/12/05BD Diabetes Care Announces Successful Results of DC Diabetes Makeover InitiativePrinter Friendly Version
07/26/05BD Board Declares DividendPrinter Friendly Version
07/22/05BD Announces Results for Third Fiscal QuarterPrinter Friendly Version
07/01/05BD Announces Agreement to Sell ClontechPrinter Friendly Version
06/09/05BD to Present at Goldman Sachs Twenty-Sixth Annual Global Healthcare ConferencePrinter Friendly Version
05/24/05BD Board Declares DividendPrinter Friendly Version
05/18/05BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference CallPrinter Friendly Version
05/18/05PreAnalytiX PAXgene(TM) Blood RNA System is Industry's First to Receive 510(K) Clearance From FDA and to Attain CE MarkPrinter Friendly Version
05/09/05BD to Present at Banc of America Securities Health Care Conference 2005Printer Friendly Version
05/05/05BD and CMMB Join Forces to Address the Challenge of HIV/AIDS Pandemic in ZambiaPrinter Friendly Version
05/04/05BD to Present at R. W. Baird 2005 Growth Stock ConferencePrinter Friendly Version
05/03/05BD Announces Acquisition of Protein Separation Technology From FFE Weber GmbHPrinter Friendly Version
04/28/05BD to Present at Morgan Stanley Third Annual Global Healthcare ConferencePrinter Friendly Version
04/27/05Webcast Alert: BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference CallPrinter Friendly Version
04/27/05BD Announces Results for Second Fiscal QuarterPrinter Friendly Version
03/24/05Webcast Alert: BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference CallPrinter Friendly Version
03/10/05BD to Present at SG Cowen 25th Annual Health Care ConferencePrinter Friendly Version
02/23/05BD Named One of America's Most Admired Companies in FORTUNE Magazine's Annual SurveyPrinter Friendly Version
02/02/05BD to Present at Merrill Lynch 2005 Global Pharmaceutical, Biotechnology & Medical Device ConferencePrinter Friendly Version
02/01/05BD Board Declares DividendPrinter Friendly Version
01/26/05BD Announces Webcast of Annual Meeting of ShareholdersPrinter Friendly Version
01/26/05BD Announces Results for Fiscal First QuarterPrinter Friendly Version
01/20/05BD to Present at 17th Annual Piper Jaffray Health Care ConferencePrinter Friendly Version
01/13/05BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference CallPrinter Friendly Version
01/10/05BD Announces FDA 510(k) Clearance of Simplified Test for Detection of Methicillin-Resistant Staphylococcus Aureus (MRSA)Printer Friendly Version
01/05/05BD to Present at 23rd Annual JPMorgan Healthcare ConferencePrinter Friendly Version
01/04/05BD Announces Tsunami Relief EffortsPrinter Friendly Version
12/15/04FIND and BD Combine International Efforts to Improve Rapid Tuberculosis Diagnosis for HIV-positive Patients in Developing CountriesPrinter Friendly Version
11/23/04BD Board Declares Dividend Increase and Authorizes Additional Share RepurchasesPrinter Friendly Version
11/23/04BD Board of Directors Elects Gary A. MecklenburgPrinter Friendly Version
11/22/04BD Releases New Version of BD.id(TM) Patient Identification System for Specimen ManagementPrinter Friendly Version
11/11/04Meeting the Challenge of InfluenzaPrinter Friendly Version
11/09/04Cellomics and BD Sign License Agreement to Further Expand Availability of High Content ScreeningPrinter Friendly Version
11/05/04BD Presents Diabetes Makeover to Inspire Better Diabetes CarePrinter Friendly Version
11/04/04FDA Alternate Site Clearance Offers BD Blood Glucose Meter Users More ConveniencePrinter Friendly Version
11/04/04BD Announces Fiscal Fourth Quarter and Full Year ResultsPrinter Friendly Version
10/26/04BD to Present at CIBC World Markets Healthcare ConferencePrinter Friendly Version
10/14/04BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference CallPrinter Friendly Version
10/06/04BD Launches Dora the Explorer(TM) Digital ThermometerPrinter Friendly Version
10/04/04BD Announces Plan to Sell ClontechPrinter Friendly Version
09/21/04BD Biosciences Releases BD FACSCanto(TM) Flow Cytometry System for Clinical DiagnosticsPrinter Friendly Version
09/16/04BD to Present at UBS Global Life Sciences ConferencePrinter Friendly Version
09/07/04BD to Present at Bear Stearns 17th Annual Healthcare ConferencePrinter Friendly Version
09/02/04BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2004 ConferencePrinter Friendly Version
07/27/04BD Board Declares DividendPrinter Friendly Version
07/27/04BD Biosciences Pharmingen Designated One of the Best Workplaces for Commuters(SM) by U.S. EPA and DOTPrinter Friendly Version
07/22/04BD Announces Results for Fiscal Third QuarterPrinter Friendly Version
07/12/04BD Highlights Social Responsibility in First Global Corporate Citizenship ReportPrinter Friendly Version
07/08/04BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference CallPrinter Friendly Version
07/02/04BD Announces Settlement of Pending LawsuitPrinter Friendly Version
07/01/04BD Announces Acquisition of Atto Bioscience, Inc.Printer Friendly Version
06/28/04BD FACSArray(TM) Bioanalyzer is Honored With a 2004 Silver Industrial Design Excellence AwardPrinter Friendly Version
06/14/04BD Names J. Peter Natale as Chief Information OfficerPrinter Friendly Version
06/10/04BD Submits 510(k) Application to FDA for Alternate Site TestingPrinter Friendly Version
06/02/04BD to Present at Goldman Sachs Twenty Fifth Annual Global Healthcare ConferencePrinter Friendly Version
05/25/04BD Board Declares DividendPrinter Friendly Version
05/24/04BD Announces FDA 510(k) Clearance of Molecular Test for Legionella pneumophilaPrinter Friendly Version
05/12/04BD to Present at Banc of America Securities 2004 Health Care ConferencePrinter Friendly Version
05/11/04BD Biosciences Releases the BD FACSCanto(TM) Flow Cytometry SystemPrinter Friendly Version
05/04/04BD(TM) Sharps Disposal By Mail System Meets EPA Guidelines, Helps Protect Public Against Injury, InfectionPrinter Friendly Version
04/30/04BD to Present at Morgan Stanley Second Annual Global Healthcare Unplugged ConferencePrinter Friendly Version
04/22/04BD Announces Fiscal Second Quarter ResultsPrinter Friendly Version
04/08/04BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference CallPrinter Friendly Version
03/29/04Basil L. Anderson Elected to BD Board of DirectorsPrinter Friendly Version
02/26/04BD to Present at the SG Cowen 24th Annual Health Care ConferencePrinter Friendly Version
01/29/04BD Initiates Voluntary Recall of Certain BD(TM) Test StripsPrinter Friendly Version
01/29/04BD Announces Fiscal First Quarter Revenue and Earnings GrowthPrinter Friendly Version
01/28/04BD to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device ConferencePrinter Friendly Version
01/27/04BD Board Authorizes Additional Share RepurchasesPrinter Friendly Version
01/27/04BD Board Declares DividendPrinter Friendly Version
01/13/04BD to Announce First Fiscal Quarter ResultsPrinter Friendly Version
12/29/03BD Names Jeffrey S. Sherman Vice President and General CounselPrinter Friendly Version
12/12/03BD Integra(TM) Syringe Maximizes Current Flu Vaccination SupplyPrinter Friendly Version
12/02/03BD to Present at Merrill Lynch Medical Technology University ConferencePrinter Friendly Version
11/24/03BD Board Declares Dividend Increase of 50%Printer Friendly Version
11/06/03BD Announces Record Fiscal Fourth Quarter and Full Year RevenuesPrinter Friendly Version
11/05/03BD to Present at Credit Suisse First Boston's Health Care ConferencePrinter Friendly Version
11/05/03BD Applauds Senate Action to Prevent Unsafe Medical Practices That Can Cause HIV/AIDS Spread in AfricaPrinter Friendly Version
11/04/03BD to Present at the CIBC World Markets Fourteenth Annual Healthcare ConferencePrinter Friendly Version
10/31/03BD Introduces New BD Ultra-Fine(TM) II, Thinnest Insulin Syringe Needle Available in USPrinter Friendly Version
10/15/03BD to Announce Fourth Fiscal Quarter and Year-End ResultsPrinter Friendly Version
10/10/03BD's VaxiNet Platform to Boost U.S. Immunization EffortsPrinter Friendly Version
09/04/03BD to Present at the Bear Stearns 16th Annual Healthcare ConferencePrinter Friendly Version
08/29/03BD to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 ConferencePrinter Friendly Version
08/22/03BD Statement Regarding Voluntary National Recall of BD ProbeTec ET InstrumentPrinter Friendly Version
07/30/03BD to Present at Adams, Harkness & Hill 23rd Annual Summer SeminarPrinter Friendly Version
07/24/03BD Announces Results for Fiscal Third QuarterPrinter Friendly Version
07/22/03BD Board Declares DividendPrinter Friendly Version
06/30/03BD to Announce Third Fiscal Quarter ResultsPrinter Friendly Version
06/05/03BD to Present at Goldman Sachs Twenty Fourth Annual Global Healthcare ConferencePrinter Friendly Version
05/20/03BD Board Declares DividendPrinter Friendly Version
05/01/03BD to Present at the 2003 Deutsche Bank Securities Health Care ConferencePrinter Friendly Version
04/25/03BD Announces Fiscal Second Quarter Results; Company Increases Earnings Guidance For Fiscal Year 2003Printer Friendly Version
04/24/03BD to Present at Morgan Stanley 1st Annual Healthcare Unplugged ConferencePrinter Friendly Version
04/22/03Edward F. DeGraan Elected to BD Board of DirectorsPrinter Friendly Version
04/16/03BD Announces Plans for Discontinuation of Conventional Needle Sales in the U.S. Across Many Product CategoriesPrinter Friendly Version
04/15/03BD CEO Edward J. Ludwig Selected to Serve on U.S.-Japan Private Sector/Government CommissionPrinter Friendly Version
04/02/03BD to Announce Second Fiscal Quarter ResultsPrinter Friendly Version
03/20/03BD Biosciences Launches New Flow Cytometry Products Incorporating Alexa Fluor(R) Dyes from Molecular ProbesPrinter Friendly Version
03/18/03BD to Present at the SG Cowen 23rd Annual Heath Care ConferencePrinter Friendly Version
03/14/03BD Names Vincent A. Forlenza President of BD BiosciencesPrinter Friendly Version
02/05/03BD Comments Further on West Pharmaceutical Services Plant IncidentPrinter Friendly Version
02/03/03BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device ConferencePrinter Friendly Version
01/29/03BD Statement in Response to West Pharmaceutical Services Plant IncidentPrinter Friendly Version
01/28/03BD Board Authorizes Additional Share RepurchasesPrinter Friendly Version
01/28/03BD Board Declares DividendPrinter Friendly Version
01/23/03BD Announces Results for Fiscal First QuarterPrinter Friendly Version
01/22/03BD to Present at the US Bancorp Piper Jaffray 15th Annual Health Care ConferencePrinter Friendly Version
01/08/03BD Introduces New Systems to Make Diabetes Monitoring and Management Easier, Faster, and Less PainfulPrinter Friendly Version
01/08/03BD Presents New Blood Glucose Monitoring Products and Announces Strategic Relationships with Medtronic MiniMed and Eli Lilly and CompanyPrinter Friendly Version
01/06/03BD to Announce First Fiscal Quarter ResultsPrinter Friendly Version
01/02/03BD to Present at the 21st Annual JP Morgan H&Q Healthcare ConferencePrinter Friendly Version
12/23/02BD Files Patent Infringement Complaint Against Tyco HealthcarePrinter Friendly Version
12/10/02BD to Present New Blood Glucose Monitoring ProductsPrinter Friendly Version
12/05/02BD Biosciences Launches New Instrument Design in the BD FACSAria Cell SorterPrinter Friendly Version
11/26/02BD Board Declares Increased DividendPrinter Friendly Version
11/06/02BD Announces Record Fiscal Fourth Quarter and Full Year RevenuesPrinter Friendly Version
11/05/02BD to Present at Credit Suisse First Boston Healthcare ConferencePrinter Friendly Version
10/28/02BD Consumer Healthcare Introduces Shortest Insulin Pen Needle Ever in the United StatesPrinter Friendly Version
10/21/02BD to Announce Fourth Fiscal Quarter and Year-End ResultsPrinter Friendly Version
09/24/02Bertram L. Scott Elected to BD Board of DirectorsPrinter Friendly Version
09/23/02BD Bifurcated Needle Launched for Smallpox Vaccination Efforts; Specialized Needle is Manufactured for International Biodefense ProgramsPrinter Friendly Version
09/18/02BD to Present at Banc of America Securities 32nd Annual Investment ConferencePrinter Friendly Version
09/16/02BD to Present at Bear Stearns 15th Annual Healthcare ConferencePrinter Friendly Version
09/10/02Tranzyme Announces the Opening of New Research Facilities at BD Technologies Incubator in Research Triangle Park, NCPrinter Friendly Version
09/10/02Tranzyme and BD Technologies Agree On Terms For A Strategic AlliancePrinter Friendly Version
09/04/02OBIT/BD Director Albert J. Costello Dies at 66Printer Friendly Version
08/02/02BD to Present at Adams, Harkness & Hill Summer SeminarPrinter Friendly Version
07/26/02U.S. Fund for UNICEF and BD Partner to Accelerate Elimination of Maternal & Neonatal TetanusPrinter Friendly Version
07/24/02BD Announces Results for Fiscal Third QuarterPrinter Friendly Version
07/23/02BD Declares DividendPrinter Friendly Version
07/19/02Statement from BD (Becton, Dickinson and Company) in response to The New York Times article Printer Friendly Version
07/01/02BD to Announce Third Fiscal Quarter ResultsPrinter Friendly Version
06/13/02BD to Present at Thomas Weisel Partners Growth Forum 4.0Printer Friendly Version
06/04/02BD to Present at Goldman Sachs 23rd Annual Global Healthcare ConferencePrinter Friendly Version
05/21/02BD Declares DividendPrinter Friendly Version
05/03/02Time Change for BD Presentation at Deutsche Bank Securities 27th Annual Healthcare ConferencePrinter Friendly Version
05/01/02BD to Present at Deutsche Bank Securities 27th Annual Healthcare ConferencePrinter Friendly Version
04/24/02BD Announces Record $1 Billion Second Quarter RevenuesPrinter Friendly Version
04/16/02BD Biosciences and NuGenesis Technologies Announce Strategic Alliance to Provide Secure Scientific Data Management Solution that Supports Regulatory RequirementsPrinter Friendly Version
04/02/02BD to Announce Second Fiscal Quarter ResultsPrinter Friendly Version
03/26/02BD to Present at Banc of America Securities Healthcare ConferencePrinter Friendly Version
02/20/02BD to Present at Lehman Brothers' 5th Annual Global Healthcare ConferencePrinter Friendly Version
02/14/02Edward J. Ludwig Becomes BD Chairman of the BoardPrinter Friendly Version
01/29/02BD to Present at Merrill Lynch Healthcare ConferencePrinter Friendly Version
01/29/02BD Biosciences Enters Into Collaboration With the Harvard Institute of Proteomics to Determine Human Gene FunctionPrinter Friendly Version
01/23/02BD Announces Results for Fiscal First QuarterPrinter Friendly Version
01/22/02BD Declares DividendPrinter Friendly Version
01/04/02BD to Present at JP Morgan H&Q Healthcare ConferencePrinter Friendly Version
01/03/02BD to Announce First Fiscal Quarter ResultsPrinter Friendly Version
11/27/01Edward J. Ludwig to Become BD Chairman of the Board Effective February 2002Printer Friendly Version
11/27/01BD Declares Increased DividendPrinter Friendly Version
11/08/01BD to Present at CSFB Health Care ConferencePrinter Friendly Version
11/07/01BD Announces Record Fiscal Fourth Quarter RevenuesPrinter Friendly Version
10/30/01BD to Announce Fourth Fiscal Quarter and Year-End ResultsPrinter Friendly Version
10/29/01BD to Present at CIBC World Markets Healthcare ConferencePrinter Friendly Version
10/04/01BD to Present at UBS Warburg Global Life Sciences ConferencePrinter Friendly Version
09/24/01BD To Participate in Bear Stearns Healthcare Virtual ConferencePrinter Friendly Version
09/24/01BD Pledges $1,000,000 to Help Victims and Families; Launches Worldwide Employee Contributions CampaignPrinter Friendly Version
09/17/01BD Board Authorizes Additional Share RepurchasesPrinter Friendly Version
09/06/01BD to Present at Bear Stearns Annual Healthcare ConferencePrinter Friendly Version
09/04/01BD to Present at Banc of America Securities Investment ConferencePrinter Friendly Version
07/30/01BD Biosciences To Collaborate With Zyomyx To Apply Antibody Expertise To High Density Protein BiochipsPrinter Friendly Version
07/25/01BD To Present at Adams, Harkness & Hill Summer SeminarPrinter Friendly Version
07/24/01BD Declares DividendPrinter Friendly Version
07/18/01BD Announces Results for Fiscal Third Quarter; Quarter And Full Year Outlook In Line With ExpectationsPrinter Friendly Version
07/18/01BD Announces Webcast of Q3 Conference Call Thursday, July 19, 2001, at 8:30 a.m. EDTPrinter Friendly Version
06/20/01BD Congratulates GlaxoSmithKline On Receiving FDA Approval to Market Prefilled Vaccine System; Pediatric Vaccines To Be Packaged with BD SafetyGlide NeedlesPrinter Friendly Version
06/13/01BD Biosciences and Dyax Corp. Announce Research Products and Proteomics AlliancePrinter Friendly Version
06/07/01BD To Present at Goldman Sachs Healthcare ConferencePrinter Friendly Version
05/22/01BD Declares DividendPrinter Friendly Version
05/01/01BD To Present at Deutsche Banc Alex. Brown 2001 Health Care ConferencePrinter Friendly Version
04/18/01BD Announces Record Revenues for Fiscal Second Quarter; Company Reaffirms Outlook for Full YearPrinter Friendly Version
04/12/01BD Announces Webcast of Q2 Conference Call; Thursday, April 19, 2001, at 8:30 a.m. EDTPrinter Friendly Version
04/04/01BD Announces Plans to Introduce Passive, Shielded I.V. CatheterPrinter Friendly Version
03/22/01BD To Present at Banc of America Securities Healthcare ConferencePrinter Friendly Version
02/22/01BD To Present At Lehman Brothers Healthcare ConferencePrinter Friendly Version
02/01/01BD to Present At Merrill Lynch Global Pharmaceutical, Medical Device & Biotechnology ConferencePrinter Friendly Version
01/23/01BD Declares DividendPrinter Friendly Version
01/23/01BD Names Dean Paranicas Vice President, Investor Relations and Public AffairsPrinter Friendly Version
01/22/01BD to Present at U.S. Bancorp Piper Jaffray Health Care ConferencePrinter Friendly Version
01/17/01BD Announces Results for Fiscal First QuarterPrinter Friendly Version
01/11/01BD Announces Webcast of Q1 Conference CallPrinter Friendly Version
12/20/00BD Signs Agreement to Acquire Gentest CorporationPrinter Friendly Version
11/28/00BD Announces Election of James Orr to Board of DirectorsPrinter Friendly Version
11/28/00BD Declares Increased DividendPrinter Friendly Version
11/21/00Cellular Technology Analyzers and BD Biosciences Enter Into an Elispot Applications Co-Development And Distribution AgreementPrinter Friendly Version
11/13/00BD To Present At CSFB Annual Healthcare ConferencePrinter Friendly Version
11/08/00BD Announces Record Revenues for Fiscal Fourth Quarter and Full Year; Results Consistent With Company's September 26, 2000 AnnouncementPrinter Friendly Version
11/02/00BD Presentation to Investment Community Notice of Live Web castPrinter Friendly Version
09/26/00BD Announces Program to Reduce Costs, Improve Financial Performance and Support Major Product InitiativesPrinter Friendly Version
09/26/00BD Names Stephen Mock Vice President, Investor and Public RelationsPrinter Friendly Version
08/18/00Letter to Analysts/InvestorsPrinter Friendly Version
07/25/00BD Declares DividendPrinter Friendly Version
07/20/00BD Announces Results for Third Fiscal Quarter; Safety and Biosciences Sales Add to Top Line GrowthPrinter Friendly Version
07/19/00BD Launches Safety Compliance Initiative for Needlestick PreventionPrinter Friendly Version
06/05/00BD Names Bridget Healy General CounselPrinter Friendly Version
05/30/00BD Names John Considine Executive VP and Chief Financial OfficerPrinter Friendly Version
05/23/00BD Declares DividendPrinter Friendly Version
04/25/00Chlamydia and Gonorrhea Now Simple to Diagnose; US Health Organizations Call for More Aggressive ScreeningPrinter Friendly Version
04/19/00BD Provides Unrestricted Grant to Support Needle Safety CampaignPrinter Friendly Version
04/18/00BD Announces Strong Results for Second Fiscal Quarter and Confirms Outlook for YearPrinter Friendly Version
02/24/00Hospital Risk Managers Find Medication Error a Significant Problem; BD Survey Reveals Reporting Errors Not RewardedPrinter Friendly Version
02/23/00BD Expects Rapid Resumption of Product Supply Following Voluntary Recall; Offers Alternate Product at No Charge in Interim and Confirms E.P.S. ExpectationsPrinter Friendly Version
01/25/00BD Declares DividendPrinter Friendly Version
01/20/00BD Reports Results for Fiscal First Quarter; Revenues Increase 12 PercentPrinter Friendly Version
11/23/99BD Names Robert M. Hallenbeck VP and General CounselPrinter Friendly Version
11/23/99BD Declares Increased DividendPrinter Friendly Version
11/22/99BD Announces Edward J. Ludwig Elected to the Board of Directors and CEOPrinter Friendly Version
11/04/99Becton Dickinson Announces Record Revenues for Fiscal YearPrinter Friendly Version
10/13/99BD Announces Chief Financial Officer Is Leaving the Company; External Search for Replacement UnderwayPrinter Friendly Version
08/31/99QIAGEN and Becton, Dickinson and Company Agree to Form Joint VenturePrinter Friendly Version
08/30/99BD Acquires Saf-T-Med Advanced Safety Needle TechnologyPrinter Friendly Version
08/26/99Becton, Dickinson and Company Completes Acquisition of Clontech Laboratories, Inc.Printer Friendly Version
08/09/99Becton, Dickinson and Company Announces Revised Agreement for Acquisition of Clontech Laboratories, Inc.Printer Friendly Version
07/27/99Becton Dickinson Declares DividendPrinter Friendly Version
07/21/99Becton Dickinson Reports Third Quarter Results; Charges Reduce Net Income by $69 MillionPrinter Friendly Version
06/14/99Becton Dickinson And Company Says Full Year Results Likely To Be Below Expectations; Also Says Voluntary Retirement Program And Other Charges For June Quarter Expected To Be $75-$100 MillionPrinter Friendly Version
05/26/99Becton Dickinson Announces Election of Willard J. Overlock, Jr.Printer Friendly Version
05/25/99Becton Dickinson Names Ludwig PresidentPrinter Friendly Version
05/25/99Becton Dickinson Declares DividendPrinter Friendly Version
04/21/99Becton Dickinson Reports 18 Percent Revenue Increase for Fiscal Second QuarterPrinter Friendly Version
02/09/99Becton Dickinson and Company Announces the Acquisition of Biometric ImagingPrinter Friendly Version
01/26/99Becton Dickinson Declares DividendPrinter Friendly Version
01/21/99Becton Dickinson Reports 16 Percent E.P.S. Increase for Fiscal First Quarter; Revenues Increase 10 PercentPrinter Friendly Version
12/14/98Becton Dickinson Acquires New Advanced Protection TechnologyPrinter Friendly Version
11/23/98Becton Dickinson Declares Increased DividendPrinter Friendly Version
11/05/98Becton Dickinson Announces Record Revenues for Fiscal YearPrinter Friendly Version
08/04/98Becton Dickinson and Company Announces Executive Vice PresidentsPrinter Friendly Version
07/28/98Becton Dickinson Declares Stock Split and Quarterly DividendPrinter Friendly Version
07/21/98Becton Dickinson Reports Third Quarter Results; Record Revenues Increase 18 Percent; Charges Reduce Net Income by $106 MillionPrinter Friendly Version
05/20/98Becton Dickinson Announces Election of Alfred Sommer to Board of DirectorsPrinter Friendly Version
05/19/98Becton Dickinson and Company Announces Restructuring Plan, One-Time Charges For Third Fiscal QuarterPrinter Friendly Version
05/19/98Becton Dickinson Declares DividendPrinter Friendly Version
04/21/98Becton Dickinson Reports 13 Percent E.P.S. Increase for Fiscal Second QuarterPrinter Friendly Version
01/29/98Becton Dickinson And Company Signs Definitive Agreement To Acquire Medical Devices Division Of The BOC GroupPrinter Friendly Version
01/27/98Becton Dickinson Declares DividendPrinter Friendly Version
01/22/98Becton Dickinson Announces Record Fiscal First Quarter ResultsPrinter Friendly Version
11/25/97Becton Dickinson Declares Increased DividendPrinter Friendly Version
11/06/97Becton Dickinson Announces Record Results for Fiscal YearPrinter Friendly Version

 

 

Powered by Thomson

[spacer image]
[spacer image][spacer image][spacer image]
[spacer image][spacer image][spacer image]
[spacer image]
Site Map
Privacy | Terms & Conditions | Permission Request | Trademarks
BD Worldwide

BD
1 Becton Drive
Franklin Lakes, NJ USA 07417
201.847.6800


Unless otherwise noted, BD, BD Logo and all other trademarks are the property of Becton, Dickinson and Company. © 2009 BD